A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Exelixis
DEKA Biosciences
Eli Lilly and Company
Herlev and Gentofte Hospital
Ikena Oncology
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Bristol-Myers Squibb
Genocea Biosciences, Inc.
University of Kansas Medical Center
Bristol-Myers Squibb